Article
Association of genetic and immuno-characteristics with clinical outcomes in patients with RET-rearranged non-small cell lung cancer: a retrospective multicenter study.
Journal of hematology & oncology - 15 Apr 2020
Lu Chang, Dong Xiao-Rong, Zhao Jun, Zhang Xu-Chao, Chen Hua-Jun, Zhou Qing, Tu Hai-Yan, Ai Xing-Hao, Chen Xiao-Feng, An Gai-Li, Bai Jun, Shan Jin-Lu, Wang Yi-Na, Yang Shuan-Ying, Liu Xiang, Zhuang Wu, Wu Hui-Ta, Zhu Bo, Xia Xue-Feng, Chen Rong-Rong, Gu De-Jian, Xu Hua-Min, Wu Yi-Long, Yang Jin-Ji
Abstract excerpt
BACKGROUND: Rearranged during transfection (RET) has been proven to be a tumorigenic target in non-small cell lung cancers (NSCLCs). In RET-rearranged NSCLCs, molecular features and their impact on prognosis were not well illustrated, and the activity of mainstay therapeutics has not currently been well compared. METHODS: Patients diagnosed with NSCLCs with RET rearrangements were analyzed for concomitant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
